-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.↓
Börse NYSE New York Stock ExchangeUSDISIN US7170811035-
PfizerBörse NYSE New York Stock ExchangeISIN US7170811035 WKN: 852009USDSymbol PFE
-
PfizerBörse Börse StuttgartISIN US717081DK61EURSymbol PFE
-
PfizerBörse Xetra FrankfurtISIN US717081ER06EURSymbol PFE
-
PFIZER INCBörse Börse HamburgISIN US717081ED10EURSymbol PFE
-
PFIZER INCBörse Börse DüsseldorfISIN XS1574158082EURSymbol PFE
-
PFIZER INCBörse Börse MünchenISIN US717081DZ31EURSymbol PFE
-
PFIZER INCBörse Gettex System der Börse MünchenISIN US717081ES88EURSymbol PFE
-
PFIZER INCBörse Tradegate System der Deutsche Börse AG (60%)ISIN US717081EQ23EURSymbol PFE
-
PFIZER INCBörse Quotrix System der Börse DüsseldorfISIN US717081DE02EURSymbol PFE
-
PFIZER INCBörse Börse FrankfurtISIN XS1574157357EURSymbol PFE
-
PfizerBörse Xetra FrankfurtEURISIN US717081EY56
-
PfizerBörse Börse MünchenEURISIN US717081FA61
-
PfizerBörse SSE Stockholm Stock ExchangeISIN US717081EZ22SEKSymbol PFE
-
PfizerBörse Bolsa Mexicana de Valore Mexiko-StadtISIN US717081EK52MXNSymbol PFE
-
PfizerBörse Bolsa de Comercio de Buenos AiresUSDISIN US717081DV27
-
PfizerBörse Bolsa Mexicana de Valore Mexiko-StadtMXNISIN US717081DH33
-
PfizerBörse BUEUSDISIN US717081EV18
-
ISIN US717081EX73EURSymbol PFE
-
PfizerBörse OMXSSEKISIN US7170811035
-
EURISIN US717081EJ89
-
PFIZER INCBörse SSEISIN US717081EP40
-
ISIN US7170811035
WKN 852009
Symbol PFE
Währung
USD
Börse
NYSE New York Stock Exchange Zeitzone: Europe/Berlin
Firmenname
Pfizer Inc
Marktkapitalisierung
197.500.079.920 (+- 10%)
Die einen sagen so, die anderen so... Es gibt 3 Datenquellen:
204.882.624.512 oder 216.419.000.000 oder 171.198.615.249
Mitarbeiter
83.400 (+- 6%)
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
88.300 oder 78.500 Mitarbeiter
Anzahl Aktien
5.558.396.599
KGV
18.68 (+- 28%)
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
23.97 oder 13.4
EBITDA 19.320.000.512
PEGRatio 4.9741
Buchwert 11.744
Zahlte zuletzt am 06.05.2021 eine Dividende von 0,39 USD . Seit damals wurde keine Dividende mehr ausgeschüttet Übersicht
Die Dividendenrendite
entsprach 4,02 % p. a.
beim aktuellen Kurs von 36,59 USD -0,04%
Pfizer underperformed den DAX um -10 % (+31 % Dividenden) vom 02.12.2013 bis 14.09.2021
Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von 36,59 USD -0,04%
Letzte Communitymeinungen
- 2 User waren zuletzt bullisch
- Im Alpha-Tester Battle 2021
-
casixxx
-
Harry386
Ein User hat Pfizer abonniert.
Aktionärsstruktur der Pfizer Inc
Portrait der Pfizer Aktie
Das Unternehmen Pfizer Inc aus USA beschäftigt 83.400 Mitarbeiter und ist in den Bereichen Chemie & Pharma, Biotechnologie, Pharma tätig.
Tochterunternehmen von Pfizer sind: Pfizer Ltd/India, PFIZER LTD., Pfizer Limited.
Die Pfizer Aktie hat inklusive der Dividendenausschüttungen seit dem 02.12.2013 eine Gesamtrendite von 88% erwirtschaftet
Das Unternehmen Pfizer Inc ist in mehr als 89 ETFs enthalten und somit ein eher allgemein bekannter Wert. Der Spitzenreiter VanEck Vectors Morningstar Durable Dividend ETF gewichtet Pfizer mit 5,94% im ETF.
Es ist auch möglich über Anleihen zu investieren. Hier findest du alle Pfizer Anleihen auf einen Blick.
Entdecke die 6 ETFs in denen Pfizer Inc am höchsten gewichtet ist Insgesamt in 89 ETFs enthalten
Dir gefallen die Informationen zu Pfizer?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
Dir gefallen die Informationen zu Pfizer?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
Dir gefallen die Informationen zu Pfizer?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
Dir gefallen die Informationen zu Pfizer?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
1.036 News & Informationen zur Pfizer Aktie
J&J’s Limbo Status Crimps U.S. Vaccine Drive at a Pivotal Moment
(Bloomberg) — Communities across the U.S.
Japan vaccine chief confirms PM Suga call with Pfizer CEO
TOKYO — Japanese Prime Minister Yoshihide Suga will hold a “courtesy call” with the head of Pfizer Inc on Saturday, Japan’s vaccine minister confirmed.
Preterm Birth Prevention and Management Market to See over 9% CAGR Through 2029
Major healthcare providers continue to use progesterone therapy extensively. However, such preventative medication is expected to decline over concerns of
Don't write off China's Covid-19 vaccines: World needs them as cases surge
Read more about Don't write off China's Covid-19 vaccines: World needs them as cases surge on Business Standard. While more than 848 million doses have been administered, countries with the highest incomes are getting vaccinated 25 times faster than those with the lowest
Olympics: Australia weighing whether to let athletes jump vaccine queue By Reuters
Olympics: Australia weighing whether to let athletes jump vaccine queue
Annual Covid-19 Vaccine Booster Shots Likely Needed, Pfizer CEO Says
Due to variants of the coronavirus, people likely will need a booster shot within a year to suppress the pool of those individuals susceptible to Covid-19, Pfizer Chief Executive Albert Bourla said Thursday.
Fauci says he believes J&J vaccine will 'get back on track soon' By Reuters
Fauci says he believes J&J vaccine will 'get back on track soon'
3 Top-Rated Dividend Stocks to Buy in Q2 2021 By StockNews
3 Top-Rated Dividend Stocks to Buy in Q2 2021
Moderna's Post-Covid Vaccines Show Promise in Clinical Trials
Moderna's Post-Covid Vaccines Show Promise in Clinical Trials, Stocks: MRNA,PFE,BNTX,JNJ,GSK, release date:Apr 15, 2021
CDC identifies small group of covid19 infections among fully vaccinated patients
Incidence is rare, occurring in only 0.008% of cases and in line with expectations
US vaccine panel delays vote on J&J covid-19 shot’s clot risk
CDC advisory group says it wants more data and plans to meet again soon on the issue
Variants fuel covid-19 surge, but scientists voice optimism for vaccines
As coronavirus strains spread, experts say public-health measures remain critical to curbing infections
Will Novavax Stock Benefit From Johnson & Johnson’s Covid Vaccine Woes?
Novavax (NASDAQ: NVAX) stock rallied by over 10% after the U.S. Food and Drug Administration and the U.S. Centers for Disease Control paused the rollout of Johnson & Johnson’s Covid-19 vaccine in the U.S. following some rare, yet severe incidents of blood clotting.
Could This Cheap COVID Vaccine Spell Doom for Pfizer and Moderna?
There's no need for alarm just yet.
Israel honors Pfizer chief Albert Bourla at Independence Day celebrations
In response to heavy lobbying from Israeli Prime Minister Benjamin Netanyahu, Bourla agreed to provide Israel with enough Pfizer/BioNTech vaccines to inoculate the country of 9.3 million people.
Everest Medicines Appoints Jennifer Yang as Chief Scientific Officer
SHANGHAI, April 15, 2021 /PRNewswire/ — Everest Medicines (HKEX 1952.HK), a biopharmaceutical company focused on developing and commercializing t…
J&J’s covid vaccine remains paused as CDC advisers seek data
The CDC’s Advisory Committee on Immunization Practices didn’t give a precise date for when they’ll reconvene to reconsider the vaccine.
Martin Capital Partners, LLC Buys General Dynamics Corp, Coca-Cola Femsa SAB de CV, Merck Inc, Sells GlaxoSmithKline PLC, Emerson Electric Co, S&P 500 ETF TRUST ETF
Martin Capital Partners, LLC Buys General Dynamics Corp, Coca-Cola Femsa SAB de CV, Merck Inc, Sells GlaxoSmithKline PLC, Emerson Electric Co, S&P 500 ETF TRUST ETF, Stocks: MRK,D,UL,JKHY,RHI,CLX,GD,KOF,HII,INGR,GOOG,GSK,SPY, release date:Apr 14, 2021
Clear Harbor Asset Management, LLC Buys Apollo Investment Corp, Manitowoc Co Inc, 3M Co, Sells AMC Networks Inc, Arthur J. Gallagher, Groupon Inc
Clear Harbor Asset Management, LLC Buys Apollo Investment Corp, Manitowoc Co Inc, 3M Co, Sells AMC Networks Inc, Arthur J. Gallagher, Groupon Inc, Stocks: MMM,BMY,PFE,ORCL,LDOS,MGI,AINV,MTW,MO,EIX,MEOH,VOD, release date:Apr 14, 2021
WTO chief lays out global action to increase vaccine access By Reuters
WTO chief lays out global action to increase vaccine access
EU Vaccine Exports Outstrip Number of Shots Given Its Own People
(Bloomberg) — The European Union continues to export more vaccines than it administers, in data highlighting the risk of a backlash against the bloc’s governments amid setbacks that keep threatening to delay its own rollout.
The EU authorized the export of 113.
Tim Jones Joins Grey As Chief Creative Officer, Pharma
NEW YORK, April 14, 2021 /PRNewswire/ — Justine Armour, Chief Creative Officer of Grey New York, today announced that Tim Jones is joining the agency as Chief
Moderna : COVID-19 shot production unlikely to rise significantly in next few months – CEO
The pace of Moderna Inc's
COVID-19 vaccine production is unlikely to speed up
markedly in the next few months, though the U.S. drugmaker
expects output to have increased significantly by 2022,… | April 14, 2021
Rhia Ventures: Shareholders Challenge Pfizer, The Home Depot, and JPMorgan Chase on Values Misalignment — Proposals Say Political Spending and Corporate Values Are at Odds
SAN FRANCISCO, April 14, 2021 /PRNewswire/ — As pressure grows on corporations to continue to speak out forcefully against efforts to restrict voter access to the polls, some shareholders are…
J&J covid-19 vaccine pause spotlights science of rare clotting disorder
Scientists are probing cause of blood clots that affected six recipients of Johnson & Johnson’s viral-vector vaccine
Denmark stops usage of AstraZeneca Covid-19 vaccine altogether, in European first
Denmark has become the first country in the European Union to drop AstraZeneca Plc’s vaccine from its Covid-19 inoculation program amid concerns over serious side effects
More colleges to require student covid-19 vaccinations
Debate over requirement ensues as school leaders say vaccinations will hasten return to in-person classes
Got $1,000? 2 Dirt-Cheap Value Stocks You Can Buy Right Now
Worried about sky-high valuations? Check out these two pharma stocks.
Wall Street Opens Higher After First Wave of Bank Earnings; Dow up 120 Pts By Investing.com
Wall Street Opens Higher After First Wave of Bank Earnings; Dow up 120 Pts
European Union Orders Extra BioNTech-Pfizer Vaccines Amid J&J Suspension
The European Union, grappling with the potential loss of Johnson & Johnson Covid-19 vaccines, will buy an additional 50 million doses from BioNTech and Pfizer for the quarter, and is in talks to purchase up to 1.8 billion more doses over the next two years.
Drugmakers Are Vying for a Multibillion-Dollar Market
Too bad there are issues with side effects.
Nature's Bounty, Solgar supplement maker files for IPO on NYSE
The Bountiful Company, a $2 billion maker of vitamin, herbal and mineral supplements formerly known as NBTY Inc. and Nature's Bounty Inc., has filed for an initial public offering. The Ronkonkoma comp
Inflation Fears Shrugged Off
Market Overview Analysis by MarketPulse (Jeffrey Halley) covering: USD/INR, Pfizer Inc, Johnson & Johnson, US Dollar Index Futures. Read MarketPulse (Jeffrey Halley)'s latest article on Investing.com
J&J delay slows Covid-19 vaccine rollout across a world needing shots
Read more about J&J delay slows Covid-19 vaccine rollout across a world needing shots on Business Standard. At a briefing Tuesday, FDA officials said the length of the pause will depend on what they learn, but they expect it to be a “matter of days”
Pfizer to pursue bringing COVID-19 vaccine to India after easing of import rules
We have noted the recent announcement with regard to the regulatory pathway for global vaccines, a Pfizer spokesperson said
J&J delay slows vaccine rollout across a world needing shots
The drugmaker suspended shots in Europe after U.S. officials paused vaccinations to review the cases of six women who suffered a type of brain blood clot similar to one reported as a rare side effect of the AstraZeneca vaccine.
The Johnson & Johnson COVID vaccine halt: here’s what investors need to know
Officials are investigating “severe” blood clots in some people.
Pfizer to deliver 10% more doses to U.S. by end of May- CEO
Pfizer Inc can deliver 10% more doses of its COVID-19 vaccine to the United States by the end of May and meet its target of supplying 300 million doses two…
Moderna : More likely to be struck by lightning? Americans weigh risk of J&J vaccine
Henna
Ramchandani walked out of her vaccine appointment at a
Washington D.C. convention center on Tuesday morning, thrilled
she had decided just one day earlier to get the Pfizer Inc
COVID-19 vaccine… | April 13, 2021
J&J Covid-19 Vaccine Pause Spotlights Science of Rare Clotting Disorder — 2nd Update
By Daniela Hernandez and Brianna Abbott
Scientists are racing to gain a better understanding of a rare blood-clotting disorder that affected six recipients of Johnson & Johnson's Covid-19… | April 13, 2021